Cyclosporine is associated with endothelial dysfunction but not with platelet activation in renal transplantation

Citation
Yc. Schrama et al., Cyclosporine is associated with endothelial dysfunction but not with platelet activation in renal transplantation, NETH J MED, 59(1), 2001, pp. 6-15
Citations number
41
Categorie Soggetti
General & Internal Medicine
Journal title
NETHERLANDS JOURNAL OF MEDICINE
ISSN journal
03002977 → ACNP
Volume
59
Issue
1
Year of publication
2001
Pages
6 - 15
Database
ISI
SICI code
0300-2977(200107)59:1<6:CIAWED>2.0.ZU;2-R
Abstract
Background: Cyclosporine (CsA) is associated with thrombotic micro-angiopat hy and endothelial dysfunction. Markers of endothelial dysfunction may serv e to identify patients at risk for development of vascular injury. In this study we measured von Willebrand Factor (vWF) and sP-selectin as possible m arkers for endothelial dysfunction in renal transplant recipients at differ ent concentrations of CsA. Because sP-selectin can also be derived from pla telets an additional in vitro study was performed to study the potential ef fect of CsA on the expression of P-selectin on platelet surface, while the effects of CSA on the interaction of platelets with Endothelial Cell Matrix (ECM) were studied under flow conditions in a perfusion chamber model. Met hods: CsA was stepwisely replaced by mycophenolate mofetil (MMF) in 15 rena l transplant recipients (more than 6 months after transplantation). VWF and sP-selectin were measured at normal CsA (median trough level 130 mug/l), l ow CsA (trough level 45 mug/l) and after stopping CsA. MMF 2 g daily was ad ded while lowering and stopping CsA. Platelet activation was investigated b y measurement of P-selectin on platelet surface by flow-cytometry (FACS), a fter incubation with CsA (0, 2, 20 and 200 mg/l) in vitro and after perfusi on of whole blood over ECM with CsA (0 or 2 mg/l, peak levels). Results: St epwise withdrawal of CsA gave a dose-related decrease of both vWF and sP-se lectin, suggesting reversible endothelial dysfunction. FACS showed no expre ssion of P-selectin on platelets by CsA. Also perfusion studies over ECM de monstrated no platelet activation by CsA but even inhibition of platelet ad hesion and aggregation. Conclusions: The use of CsA is not accompanied by p latelet activation. However endothelial dysfunction induced by CsA does occ ur as reflected by increased vWF and sP-selectin. (See Editorial p. 1). (C) 2001 Elsevier Science BY All rights reserved.